Kratom as Cancer Chemopreventive Functional Food: A Provocative Review

Why it matters

A new review argues that kratom's rich alkaloid and polyphenol profile may make it a candidate functional food for cancer chemoprevention — a provocative but scientifically grounded perspective backed by in vitro evidence.

The big picture

While kratom's risks are well-publicized, this review highlights a largely overlooked frontier: its potential anti-cancer properties. If validated in clinical trials, this could transform how kratom is perceived by regulators, oncologists, and the public.

Key findings

• • Kratom alkaloids (mitragynine, 7-HMG) have demonstrated selective apoptosis induction, cell cycle arrest, and cancer cell migration inhibition in vitro
• • Non-alkaloidal kratom compounds (rutin, procyanidin) show antioxidant activity and topoisomerase IIα inhibition — another anti-cancer mechanism
• • Kratom alkaloids may synergize with conventional chemotherapeutic agents, potentially enhancing their efficacy
• • Bioavailability challenges, psychoactive properties, and drug-food interactions present significant hurdles to clinical development
• • Authors call for controlled human trials, advanced formulations, and harmonized legal frameworks before any clinical application

Bottom line

Perspective/review by researchers from Universitas Brawijaya, Universitas Airlangga, Erasmus MC, and other Indonesian institutions; published in Journal of Agriculture and Food Research (November 2025).